Screening for Hepatocellular Carcinoma Recurrence After Liver Transplantation: Prospective Validation of Binary Criteria
These prospectively validated criteria offer clinicians a practical tool for easily and accurately determining which patients would benefit from surveillance for HCC recurrence after LT. Surveillance targeting only high-risk patients could reduce the harms of excess screening.
Authors
- Meagan Gray (ORCID: https://orcid.org/0000-0001-7556-8985)
- Kai Ha (ORCID: https://orcid.org/0000-0003-3156-7344)
- Stephen D. Zucker (ORCID: https://orcid.org/0000-0003-1451-905X)
- Christina N. Brown
- Jordan Sack (ORCID: https://orcid.org/0000-0003-3313-7313)
- Shaun Chandna (ORCID: https://orcid.org/0000-0001-8293-7005)
- Wesley Dixon (ORCID: https://orcid.org/0000-0002-5080-1522)
- Sampath Poreddy
- Michael Schoech (ORCID: https://orcid.org/0009-0002-6255-2807)
Institutions
- Creighton University (US)
- OhioHealth (US)
- Brigham and Women's Hospital (US)
- University of Alabama at Birmingham (US)
- Alternatives Research & Development Foundation (US)
- Olive View-UCLA Medical Center (US)
- University of Cincinnati (US)
- University of Cincinnati Medical Center (US)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-11-29
- DOI
- https://doi.org/10.1002/cam4.71428
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Massachusetts General Hospital
- University of Cincinnati